Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,411
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Arlington VA, Reston VA, Fairfax VA, Manassas VA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase3, Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: Fairfax VA, Baltimore MD, New Castle DE, Pittsburgh PA,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
Location: Reston VA, Baltimore MD, Exton PA, Wyomissing PA,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04692493
Phase3, Recruiting
Active & Responsive
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
for
Atherosclerotic Cardiovascular Disease (ASCVD)
Location: Falls Church VA, Ft. Washington MD, Bowie MD, Summit NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06813911
Phase3, Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Fairfax VA, Columbia MD, Newark DE, Philadelphia PA,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Fairfax VA, Columbia MD, Asheville NC, Ann Arbor MI,
Sponsor: Zenith Epigenetics
Sex: Male
Age: 18+
Code: NCT04986423
Phase2, Recruiting
Active & Responsive
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Fairfax VA, Baltimore MD, Columbus OH, Lexington KY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT05142189
Phase1, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Fairfax VA, Brandywine MD, Doylestown PA, Pittsburgh PA,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase2, Recruiting
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Fairfax VA, Baltimore MD, Media PA, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase3, Recruiting
Active & Responsive
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Tumor,
Location: Fairfax VA, Baltimore MD, Hampton VA, New York NY,
Sponsor: Proton Collaborative Group
Sex: Female
Age: 50+
Code: NCT01766297
Phase2, Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Falls Church VA, Baltimore MD, Nottingham MD,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase3, Recruiting
Active & ResponsiveNew
Tirzepatide for Treatment of CCCA
for
Central Centrifugal Cicatricial Alopecia (CCCA)
Location: Columbia MD, Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 70+
Code: NCT07734870
Phase2, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Hyattsville MD, Baltimore MD, Uniontown PA, Norfolk VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase3, Recruiting
Active & Responsive
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Columbia MD, Baltimore MD, Charlottesville VA,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07100990
Phase3, Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Columbia MD, Annapolis MD, Hampton VA, Newark NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Columbia MD, Bowie MD, Camp Hill PA, Richmond VA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Oxon Hill MD, Uniontown PA, Wilmington NC,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18 - 70+
Code: NCT07668388
Phase2, Recruiting
Active & Responsive
TMS for Inhibition Enhancement in Schizophrenia
for
Schizophrenia
Location: Catonsville MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 45
Code: NCT06155682
Recruiting
Active & Responsive
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Baltimore MD, New York NY, Stony Brook NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06535607
Phase2, Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Glen Burnie MD, New York NY, Mentor OH, Toronto, London,